Showing results (81-90 of 125) with videos related to
Sort By:
Pageof 13
Oncotarget|July 25, 2018
RET fusions observed in lung and colorectal cancers are sensitive to ponatinibJoseph M Gozgit, Tzu-Hsiu Chen, Youngchul Song, et al.Medrxiv : the Preprint Server for Health Sciences|August 23, 2023
Oral SARS-CoV-2 host responses predict the early COVID-19 disease courseWilliam T Seaman, Olive Keener, Wenwen Mei, et al.Plos One|February 25, 2012
Large fragment pre-S deletion and high viral load independently predict hepatitis B relapse after liver transplantationTing-Jung Wu, Tse-Ching Chen, Frank Wang, et al.Research Square|August 30, 2023
Oral SARS-CoV-2 host responses predict the early COVID-19 disease courseWilliam T Seaman, Olive Keener, Wenwen Mei, et al.Cancer Medicine|August 28, 2015
A simple risk stratification model that predicts 1-year postoperative mortality rate in patients with solid-organ cancerWen-Chi Chou, Frank Wang, Yu-Fan Cheng, et al.Cancer Chemotherapy and Pharmacology|March 8, 2013
Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer modelsJoseph M Gozgit, Rachel M Squillace, Matthew J Wongchenko, et al.Bioanalysis|August 16, 2023
A sensitive LC-MS/MS assay to quantitate free payload Aur0101 from ADC PYX-201 in rat and monkey plasmaFeng Yin, Farah Ahsan, Jan Pinkas, et al.Biorxiv : the Preprint Server for Biology|July 3, 2023
A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levelsAlena J Markmann, D Ryan Bhowmik, Baowei Jiang, et al.Molecular Cancer Therapeutics|January 13, 2012
Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer modelsJoseph M Gozgit, Matthew J Wong, Lauren Moran, et al.JAMA Network Open|January 27, 2023
Comparison of Preprint Postings of Randomized Clinical Trials on COVID-19 and Corresponding Published Journal Articles: A Systematic ReviewAnthony D Bai, Yunbo Jiang, David L Nguyen, et al.Pageof 13